Roa | Jotup

Another Medicine to Stop Migraine in its Tracks – Zavzpret™ is Now Available, but Where will Neurologists use it?

Retrieved on:

Thursday, August 17, 2023

Now with the July commercial availability of Zavzpret, Spherix has begun tracking its launch in the Launch Dynamix™: Zavzpret for Acute Treatment of Migraine study.

Key Points:

Now with the July commercial availability of Zavzpret, Spherix has begun tracking its launch in the Launch Dynamix™: Zavzpret for Acute Treatment of Migraine study.
As of June, over three-quarters of physicians planned to prescribe Zavzpret to their migraine patients within the first six months of availability.
One way to tease apart the relative advantages and disadvantages of new migraine therapies is to utilize Spherix’s Launch Dynamix™: Zavzpret series.
Spherix will be tracking the awareness and perception of these investigational, pipeline therapies in its separate service, RealTime Dynamix™.

Aquavit Files Two IND's For Its Botulinum Toxin With FDA

Retrieved on:

Friday, March 17, 2023

AB toxin, Neurotoxin, Roa, Hyperhidrosis, Toxicity, Botulinum toxin, Physician, AAD, Knowledge, FDA, IND, Clostridium botulinum, Pharmaceutical industry, Canning, Dermatology, Aquavit

NEW YORK, March 17, 2023 /PRNewswire/ -- Aquavit Holdings, the exclusive licensee of Huons Global's Botulinum Toxin in the USA and Canada, will officially unveil the Aquatox™ program at the Annual American Academy of Dermatology - 2023, the world's largest dermatology conference scheduled from March 17-21, 2023, in New Orleans, LA.

Key Points:

According to The Aesthetic Society and the Global Market Insights, botulinum toxin has been the #1 non-surgical aesthetic procedure since 1999 and is still growing rapidly with only 4 companies with approved botulinum toxin in the US.
With a projected CAGR of 7-9%, the global botulinum toxin market in 2026 is expected to be $8.9B.
For several years, Aquavit has been investing in its proprietary delivery technologies and related intellectual property for botulinum toxin.
We plan to introduce the most innovative botulinum toxin products, uplift and modernize the treatment paradigm" said Sobin Chang, CEO of Aquavit.

Life Science Analytics Market worth $47.5 billion | MarketsandMarkets.

Retrieved on:

Friday, February 10, 2023

Roa, Maintenance, Pressure, Software, Research, Row, Pharmacovigilance, Marketing, Growth, Roe, Retail, Fine chemical

North America (US and Canada), Asia (Japan, China, India, and RoA), Europe (Germany, UK, France,Italy, and RoE), and the Rest of the World

Key Points:

North America (US and Canada), Asia (Japan, China, India, and RoA), Europe (Germany, UK, France,Italy, and RoE), and the Rest of the World
Based on type, the life science analytics market is bifurcated into descriptive analytics, predictive analytics, and prescriptive analytics.
"Services segment to grow at the highest CAGR in the life science analytics market during the forecast period, by component"
Based on component, the life science analytics market is segmented into services and software.
In 2022, the services segment was expected to account for the largest market share of the life science analytics market.
In 2022, research & development is expected to account for the largest share of the life science analytics market.

Life Science Analytics Market worth $47.5 billion | MarketsandMarkets.

Retrieved on:

Friday, February 10, 2023

Roa, Maintenance, Pressure, Software, Research, Row, Pharmacovigilance, Marketing, Growth, Roe, Retail, Fine chemical

North America (US and Canada), Asia (Japan, China, India, and RoA), Europe (Germany, UK, France,Italy, and RoE), and the Rest of the World

Key Points:

North America (US and Canada), Asia (Japan, China, India, and RoA), Europe (Germany, UK, France,Italy, and RoE), and the Rest of the World
Based on type, the life science analytics market is bifurcated into descriptive analytics, predictive analytics, and prescriptive analytics.
"Services segment to grow at the highest CAGR in the life science analytics market during the forecast period, by component"
Based on component, the life science analytics market is segmented into services and software.
In 2022, the services segment was expected to account for the largest market share of the life science analytics market.
In 2022, research & development is expected to account for the largest share of the life science analytics market.